TaiRxROCO:6580 74 Days Payable is 20.87 as of Dec. 2025, which is 89% below its 10-year median of 192.72. GuruFocus rates ROCO:6580 with a GF Score™ of 74/100 and a GF Value™ of NT$107.47 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 701 Biotechnology companies, TaiRx ranks worse than 83.88% on this metric.
TaiRx's average Accounts Payable for the
six
months ended in Dec. 2025 was NT$1.28 Mil. TaiRx's Cost of Goods Sold for the
six
months ended in Dec. 2025 was NT$11.17 Mil.
Hence, TaiRx's Days Payable for the
six
months ended in Dec. 2025 was 20.87.
The historical rank and industry rank for TaiRx's Days Payable or its related term are showing as below:
ROCO:6580'
s Days Payable Range Over the Past 10 Years
Min: 26.21 Med: 192.72 Max: 296.83
Current: 26.21
During the past 11 years, TaiRx's highest Days Payable was 296.83. The lowest was 26.21. And the median was 192.72.
ROCO:6580's Days Payable is ranked worse than 83.88% of 701
companies
in the Biotechnology industry
Industry Median: 112.84
vs ROCO:6580: 26.21
TaiRx's Days Payable
increased
from Dec. 2024 (0.00) to Dec. 2025 (20.87).
It may suggest that TaiRxdelayed paying its suppliers.
TaiRx Days Payable Related Terms
TaiRx Days Payable Historical Data
* Premium members only.
The historical data trend for TaiRx's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6580 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, TaiRx's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiRx Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TaiRx's Days Payable distribution charts can be found below:
* The bar in red indicates where TaiRx's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
TaiRx's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TaiRx (ROCO:6580) has a Days Payable of 20.87 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TaiRx and its competitors. This is 89% below median its historical median of 192.72. Over the past decade, TaiRx's Days Payable has ranged from 26.21 to 296.83. According to the industry distribution chart, TaiRx ranks #588 out of 701 companies in the Biotechnology industry, placing it in the top 83.9%.
Is TaiRx's Days Payable too high?
TaiRx's current Days Payable of 20.87 is 89% below median its 10-year median of 192.72. Over the past 10 years, this metric has ranged from a low of 26.21 to a high of 296.83. The Biotechnology industry median Days Payable is 112.84. TaiRx's value of 20.87 is 81.5% below this industry median. Based on the distribution chart, TaiRx ranks #588 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, TaiRx has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TaiRx's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TaiRx ranks #588 out of 701 companies for Days Payable. This places TaiRx in the lower half of its industry. The industry median Days Payable is 112.84. TaiRx's value of 20.87 is 81.5% below this benchmark. Historically, TaiRx's own Days Payable has ranged from 26.21 to 296.83 over the past decade. While the company's 10-year median is 192.72 vs. the industry median of 112.84, TaiRx has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TaiRx's current Days Payable of 20.87 is 81.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TaiRx and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TaiRx's current Days Payable is 20.87, which is 89% below median its own 10-year median of 192.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiRx stock overvalued right now?
Based on GuruFocus' analysis, TaiRx (ROCO:6580) is currently considered Possible Value Trap. The stock's GF Value™ is NT$107.47, compared to a current price of NT$13.05 — trading 87.9% below its estimated fair value. The current Days Payable is 20.87, which is 89% below median its 10-year median of 192.72 and 81.5% below the Biotechnology industry median of 112.84. TaiRx's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For TaiRx (ROCO:6580), the current Days Payable is 20.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiRx (ROCO:6580) Overvalued in 2026?
Based on GuruFocus' analysis, TaiRx stock appears to be undervalued.
The current stock price of NT$13.05 is trading 87.9% below its estimated GF Value™ of NT$107.47.
GuruFocus considers TaiRx to be Possible Value Trap.
Key valuation signals for ROCO:6580:
Days Payable: 20.87 (89% below median its 10-year median of 192.72)
GF Value™: NT$107.47 vs. price of NT$13.05 (87.9% below fair value)
Industry Position: 81.5% below the Biotechnology median (#588 of 701)
No single metric tells the full story. See the ROCO:6580 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiRx Inc is a pharmaceutical company based in Taiwan. It develops new drugs and improves current standard treatments to promptly find cures for diseases and fulfill unmet medical needs. The company focuses on new drug development for Asia and other markets.
74GF Score
Get the complete analysis for ROCO:6580
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6580 has been successfully added to your 
